Table 1.
Baseline characteristics of stroke patients.
| Mild (n = 16) | Moderate (n = 15) | Severe (n = 15) | p-value | |
|---|---|---|---|---|
| Age (years) | 67.44 ± 12.36 | 61.87 ± 14.28 | 57.73 ± 13.05 | 0.134 |
| Man (n, %) | 12 (75%) | 8 (53%) | 11 (73%) | 0.451 |
| Lesion type, Ischemic (n, %) | 15 (94%) | 13 (87%) | 12 (80%) | 0.489 |
| Duration (months) | 2.19 ± 1.22 | 2.00 ± 1.13 | 2.40 ± 1.76 | 0.737 |
| FMA-UE | 61.94 ± 3.02 | 34.13 ± 5.93* | 22.00 ± 3.02*,** | <0.001 |
| WMFT | 67.00 ± 9.85 | 31.13 ± 14.94* | 19.87 ± 3.23*,** | <0.001 |
| MI | 77.38 ± 7.76 | 59.20 ± 12.05* | 41.93 ± 11.00*,** | <0.001 |
| TCT | 99.19 ± 3.25 | 92.27 ± 17.35 | 90.60 ± 20.65 | 0.271 |
Values are expressed as mean ± standard deviation. * Post hoc analysis, compared with the mild group, p < 0.05. ** Post hoc analysis, compared with the moderate group, p < 0.05. FMA-UE, Fugl-Meyer assessment for upper extremity; WMFT, Wolf motor function test; MI, motricity index; TCT, trunk control test.